位置:首页 > 蛋白库 > RHBL2_HUMAN
RHBL2_HUMAN
ID   RHBL2_HUMAN             Reviewed;         303 AA.
AC   Q9NX52; B2RNT3; B9EH75; Q6P175; Q8NER8; Q96E02;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=Rhomboid-related protein 2;
DE            Short=RRP2;
DE            EC=3.4.21.105;
DE   AltName: Full=Rhomboid-like protein 2;
DE   Contains:
DE     RecName: Full=Rhomboid-related protein 2, N-terminal fragment;
DE              Short=NTF;
DE   Contains:
DE     RecName: Full=Rhomboid-related protein 2, C-terminal fragment;
DE              Short=CTF;
GN   Name=RHBDL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Jiao W., Yuan W., Wu X.;
RT   "Cloning and characterization of RHBDL2, a novel rhomboid-like gene, in
RT   human development.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Adrenal cortex, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 11-303 (ISOFORM 1).
RC   TISSUE=Gastric carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF TRP-121; ARG-122; ASN-139; GLY-185; SER-187
RP   AND HIS-250.
RX   PubMed=11672525; DOI=10.1016/s0092-8674(01)00525-6;
RA   Urban S., Lee J.R., Freeman M.;
RT   "Drosophila Rhomboid-1 defines a family of putative intramembrane serine
RT   proteases.";
RL   Cell 107:173-182(2001).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF SER-187.
RX   PubMed=15047175; DOI=10.1016/j.bbrc.2004.03.039;
RA   Pascall J.C., Brown K.D.;
RT   "Intramembrane cleavage of ephrinB3 by the human rhomboid family protease,
RT   RHBDL2.";
RL   Biochem. Biophys. Res. Commun. 317:244-252(2004).
RN   [7]
RP   CATALYTIC ACTIVITY, PROTEOLYTIC PROCESSING, MUTAGENESIS OF TRP-121 AND
RP   ARG-122, AND SUBCELLULAR LOCATION.
RX   PubMed=19850051; DOI=10.1016/j.jmb.2009.10.025;
RA   Lei X., Li Y.M.;
RT   "The processing of human rhomboid intramembrane serine protease RHBDL2 is
RT   required for its proteolytic activity.";
RL   J. Mol. Biol. 394:815-825(2009).
CC   -!- FUNCTION: Involved in regulated intramembrane proteolysis and the
CC       subsequent release of functional polypeptides from their membrane
CC       anchors. Known substrate: EFNB3. {ECO:0000269|PubMed:11672525,
CC       ECO:0000269|PubMed:15047175}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Cleaves type-1 transmembrane domains using a catalytic dyad
CC         composed of serine and histidine that are contributed by different
CC         transmembrane domains.; EC=3.4.21.105;
CC         Evidence={ECO:0000269|PubMed:19850051};
CC   -!- INTERACTION:
CC       Q9NX52-3; Q969S0: SLC35B4; NbExp=3; IntAct=EBI-12908426, EBI-10281213;
CC       Q9NX52-3; P55061: TMBIM6; NbExp=3; IntAct=EBI-12908426, EBI-1045825;
CC   -!- SUBCELLULAR LOCATION: [Rhomboid-related protein 2, C-terminal
CC       fragment]: Cell membrane {ECO:0000269|PubMed:19850051}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NX52-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NX52-3; Sequence=VSP_012692;
CC   -!- PTM: Proteolytic processing of the proenzyme produces a N-terminal
CC       fragment (NTF) and a C-terminal fragment (CTF). The processing is
CC       required for activation of the protease. {ECO:0000269|PubMed:19850051}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to an intron retention.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the peptidase S54 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13103.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA91168.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY126343; AAM95697.1; -; mRNA.
DR   EMBL; AL139260; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013103; AAH13103.1; ALT_INIT; mRNA.
DR   EMBL; BC137108; AAI37109.1; -; mRNA.
DR   EMBL; BC137110; AAI37111.1; -; mRNA.
DR   EMBL; AK000442; BAA91168.1; ALT_INIT; mRNA.
DR   CCDS; CCDS30680.1; -. [Q9NX52-1]
DR   RefSeq; NP_060291.2; NM_017821.4. [Q9NX52-1]
DR   AlphaFoldDB; Q9NX52; -.
DR   SMR; Q9NX52; -.
DR   BioGRID; 120273; 5.
DR   IntAct; Q9NX52; 3.
DR   STRING; 9606.ENSP00000289248; -.
DR   MEROPS; S54.002; -.
DR   iPTMnet; Q9NX52; -.
DR   PhosphoSitePlus; Q9NX52; -.
DR   BioMuta; RHBDL2; -.
DR   DMDM; 59800189; -.
DR   jPOST; Q9NX52; -.
DR   MassIVE; Q9NX52; -.
DR   MaxQB; Q9NX52; -.
DR   PaxDb; Q9NX52; -.
DR   PeptideAtlas; Q9NX52; -.
DR   PRIDE; Q9NX52; -.
DR   ProteomicsDB; 83039; -. [Q9NX52-1]
DR   ProteomicsDB; 83040; -. [Q9NX52-3]
DR   Antibodypedia; 31843; 96 antibodies from 24 providers.
DR   DNASU; 54933; -.
DR   Ensembl; ENST00000289248.6; ENSP00000289248.2; ENSG00000158315.11. [Q9NX52-1]
DR   Ensembl; ENST00000372990.6; ENSP00000362081.1; ENSG00000158315.11. [Q9NX52-1]
DR   Ensembl; ENST00000540558.1; ENSP00000441097.1; ENSG00000158315.11. [Q9NX52-3]
DR   GeneID; 54933; -.
DR   KEGG; hsa:54933; -.
DR   MANE-Select; ENST00000372990.6; ENSP00000362081.1; NM_017821.5; NP_060291.2.
DR   UCSC; uc001ccu.1; human. [Q9NX52-1]
DR   CTD; 54933; -.
DR   DisGeNET; 54933; -.
DR   GeneCards; RHBDL2; -.
DR   HGNC; HGNC:16083; RHBDL2.
DR   HPA; ENSG00000158315; Tissue enhanced (esophagus).
DR   MIM; 608962; gene.
DR   neXtProt; NX_Q9NX52; -.
DR   OpenTargets; ENSG00000158315; -.
DR   PharmGKB; PA34383; -.
DR   VEuPathDB; HostDB:ENSG00000158315; -.
DR   eggNOG; KOG2289; Eukaryota.
DR   GeneTree; ENSGT00940000159442; -.
DR   HOGENOM; CLU_048023_0_0_1; -.
DR   InParanoid; Q9NX52; -.
DR   OMA; VCCDQLM; -.
DR   PhylomeDB; Q9NX52; -.
DR   TreeFam; TF313540; -.
DR   BRENDA; 3.4.21.105; 2681.
DR   PathwayCommons; Q9NX52; -.
DR   SignaLink; Q9NX52; -.
DR   BioGRID-ORCS; 54933; 13 hits in 1063 CRISPR screens.
DR   ChiTaRS; RHBDL2; human.
DR   GenomeRNAi; 54933; -.
DR   Pharos; Q9NX52; Tbio.
DR   PRO; PR:Q9NX52; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9NX52; protein.
DR   Bgee; ENSG00000158315; Expressed in mucosa of sigmoid colon and 141 other tissues.
DR   Genevisible; Q9NX52; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1540.10; -; 1.
DR   InterPro; IPR022764; Peptidase_S54_rhomboid_dom.
DR   InterPro; IPR017213; Peptidase_S54_rhomboid_met.
DR   InterPro; IPR035952; Rhomboid-like_sf.
DR   Pfam; PF01694; Rhomboid; 1.
DR   PIRSF; PIRSF037470; Rhomboid; 1.
DR   SUPFAM; SSF144091; SSF144091; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Hydrolase; Membrane; Protease;
KW   Reference proteome; Serine protease; Transmembrane; Transmembrane helix.
FT   CHAIN           1..303
FT                   /note="Rhomboid-related protein 2"
FT                   /id="PRO_0000206176"
FT   CHAIN           1..?
FT                   /note="Rhomboid-related protein 2, N-terminal fragment"
FT                   /id="PRO_0000408510"
FT   CHAIN           ?..303
FT                   /note="Rhomboid-related protein 2, C-terminal fragment"
FT                   /id="PRO_0000408509"
FT   TRANSMEM        72..92
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        128..148
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        159..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        183..203
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        212..232
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        245..265
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        278..298
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          20..39
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        187
FT                   /note="Nucleophile"
FT   ACT_SITE        250
FT   VAR_SEQ         133..303
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012692"
FT   VARIANT         273
FT                   /note="L -> M (in dbSNP:rs2147914)"
FT                   /id="VAR_020328"
FT   MUTAGEN         121
FT                   /note="W->A: Reduces protease activity."
FT                   /evidence="ECO:0000269|PubMed:11672525,
FT                   ECO:0000269|PubMed:19850051"
FT   MUTAGEN         122
FT                   /note="R->A: Abolishes protease activity, prevents
FT                   processing and alters localization to the plasma membrane
FT                   of N-terminal fragment."
FT                   /evidence="ECO:0000269|PubMed:11672525,
FT                   ECO:0000269|PubMed:19850051"
FT   MUTAGEN         139
FT                   /note="N->A: Reduces protease activity."
FT                   /evidence="ECO:0000269|PubMed:11672525"
FT   MUTAGEN         185
FT                   /note="G->A: Abolishes protease activity."
FT                   /evidence="ECO:0000269|PubMed:11672525"
FT   MUTAGEN         187
FT                   /note="S->A,G: Abolishes protease activity."
FT                   /evidence="ECO:0000269|PubMed:11672525,
FT                   ECO:0000269|PubMed:15047175"
FT   MUTAGEN         250
FT                   /note="H->A: Abolishes protease activity."
FT                   /evidence="ECO:0000269|PubMed:11672525"
SQ   SEQUENCE   303 AA;  34021 MW;  2B6CB8291319C2D9 CRC64;
     MAAVHDLEME SMNLNMGREM KEELEEEEKM REDGGGKDRA KSKKVHRIVS KWMLPEKSRG
     TYLERANCFP PPVFIISISL AELAVFIYYA VWKPQKQWIT LDTGILESPF IYSPEKREEA
     WRFISYMLVH AGVQHILGNL CMQLVLGIPL EMVHKGLRVG LVYLAGVIAG SLASSIFDPL
     RYLVGASGGV YALMGGYFMN VLVNFQEMIP AFGIFRLLII ILIIVLDMGF ALYRRFFVPE
     DGSPVSFAAH IAGGFAGMSI GYTVFSCFDK ALLKDPRFWI AIAAYLACVL FAVFFNIFLS
     PAN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024